Classical and atypical neuroblastoma - Case reports

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 2, 2011, Pages 134-136

  Csáthy, Lászlõ ^a   Kappelmayer, János ^a   Szegedi, István ^a   Kajtár, Béla ^a   Kiss, Csongor ^a   Hevessy, Zsuzsanna ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

bone marrow analysis; flow cytometry; neuroblastoma

Indexed keywords

CATECHOLAMINE; CD45 ANTIGEN; CD56 ANTIGEN; CD81 ANTIGEN; FERRITIN; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; STEM CELL FACTOR RECEPTOR;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CATECHOLAMINE URINE LEVEL; CELL INFILTRATION; CELL STRUCTURE; CHILD; DISEASE COURSE; DISEASE MARKER; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; MEDIASTINUM TUMOR; NEUROBLASTOMA; NEUROBLASTOMA CELL; PHYSICAL EXAMINATION; PLURIPOTENT STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; ROSETTE FORMATION;

ANTIGENS, CD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; NEUROBLASTOMA; SENSITIVITY AND SPECIFICITY;

EID: 79951933953     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20576     Document Type: Article

References (11)

1. Nyari TA, Kajtar P, Parker L,. Neuroblastoma in Hungary. Eur J Cancer 2006; 42: 2350-2354. (Pubitemid 44316898)
2. Tornoczky T, Semjen D, Shimada H, Ambros IM,. Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated/ poorly differentiated neuroblastoma. Pathol Oncol Res 2007; 13: 269-275. (Pubitemid 351287306)
3. Ross JA, Davies SM,. Screening for neuroblastoma: Progress and pitfalls. Cancer Epidemiol Biomarkers Prev 1999; 8: 189-194. (Pubitemid 29085388)
4. Papaioannou G, McHugh K,. Neuroblastoma in childhood: Review and radiological findings. Cancer Imaging 2005; 5: 116-127.
5. Reid MM, Roald B,. Central review of bone marrow biopsy specimens from patients with neuroblastoma. J Clin Pathol 1996; 49: 691-692. (Pubitemid 26264405)
6. Weinstein JL, Katzenstein HM, Cohn SL,. Advances in the diagnosis and treatment of neuroblastoma. Oncologist 2003; 8: 278-292. (Pubitemid 36648814)
7. Sterba J, Pavelka Z, Andre N, Ventruba J, Skotakova J, Bajciova V, Bronisova D, Dubska L, Valik D,. Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy. Pediatr Blood Cancer 2010; 54: 616-617.
8. Warzynski MJ, Graham DM, Axtell RA, Higgins JV, Hammers YA,. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients. Cytometry 2002; 50: 298-304. (Pubitemid 37509505)
9. Swerts K, De Moerloose B, Dhooge C, Brichard B, Benoit Y, Laureys G, Philippe J,. Detection of residual neuroblastoma cells in bone marrow: Comparison of flow cytometry with immunocytochemistry. Cytometry Part B 2004; 61B: 9-19. (Pubitemid 39223365)
10. Nowicki M, Ostalska-Nowicka D, Miskowiak B,. Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: Preliminary report. J Clin Pathol 2006; 59: 150-152. (Pubitemid 43235578)
11. Beck D, Gross N, Brognara CB, Perruisseau G,. Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors. Blood 1995; 86: 3132-3138.